Huashan C. Liu
26 Yuancun Erheng Rd
Guangzhou, 510655, China
Guangzhou, 510655, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Is neoadjuvant chemoradiotherapy necessary for locally advanced rectal cancer above the anterior peritoneal reflection?
Journal: Future oncology (London, England)
Published: November 10, 2025
G3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer.
Journal: Cell communication and signaling : CCS
Published: September 25, 2025
KDM4A-induced tumor senescence enhances the efficacy of immunotherapy by inhibiting AGT-PHB1 axis-mediated mitophagy in colorectal cancer.
Journal: Autophagy
Published: September 09, 2025
Exclusive enteral nutrition and the risk of nonsurgical readmission in patients with Crohn's disease-related intra-abdominal abscess: A retrospective cohort study.
Journal: JPEN. Journal of parenteral and enteral nutrition
Published: July 11, 2025
ANGPTL3 promotes colorectal carcinoma progression and metastasis through regulating COL1A2 transcription via interacting with integrin αVβ3.
Journal: Cancer letters
Published: July 08, 2025
Lactylation at lysine 145 fosters KAT8-TIP60 complex formation to promote p53 acetylation at lysine 120 and its pro-apoptotic function.
Journal: Nature communications
Published: May 22, 2025
Dynamic Arginine Methylation of YBX1 Relay Controls Its Phase Separation and Chemoradiotherapy Resistance in Rectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 13, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial.
Journal: JAMA
Published: January 23, 2025
Glutamic-pyruvic transaminase 1 deficiency-mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression.
Journal: Science translational medicine
Published: January 01, 2025
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.
Journal: Nature communications
Published: November 25, 2024
PHLDA1 protects intestinal barrier function via restricting intestinal epithelial cells apoptosis in inflammatory bowel disease.
Journal: Experimental cell research
Published: May 27, 2024
Last Updated: 09/26/2026